The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction
Open accessAbstract
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognition of myocardial injury in acute illnesses other than acute coronary syndrome. The Universal Definition of Myocardial Infarction recommends high-sensitivity cardiac troponin testing and classification of patients with myocardial injury based on pathogenesis, but the clinical implications of implementing this guideline are not well understood. Methods: In a stepped-wedge cluster randomized, controlled trial, we implemented a high-sensitivity cardiac troponin assay and the recommendations of the Universal Definition in 48 282 consecutive patients with suspected acute coronary syndrome. In a prespecified secondary analysis, we compared the primary outcome of myocardial infarction or cardiovascular death and secondary outcome of noncardiovascular death at 1 year across diagnostic categories. Results: Implementation increased the diagnosis of type 1 myocardial infarction by 11% (510/4471), type 2 myocardial infarction by 22% (205/916), and acute and chronic myocardial injury by 36% (443/1233) and 43% (389/898), respectively. Compared with those without myocardial injury, the rate of the primary outcome was highest in those with type 1 myocardial infarction (cause-specific hazard ratio [HR] 5.64 [95% CI, 5.12–6.22]), but was similar across diagnostic categories, whereas noncardiovascular deaths were highest in those with acute myocardial injury (cause specific HR 2.65 [95% CI, 2.33–3.01]). Despite modest increases in antiplatelet therapy and coronary revascularization after implementation in patients with type 1 myocardial infarction, the primary outcome was unchanged (cause specific HR 1.00 [95% CI, 0.82–1.21]). Increased recognition of type 2 myocardial infarction and myocardial injury did not lead to changes in investigation, treatment or outcomes. Conclusions: Implementation of high-sensitivity cardiac troponin assays and the recommendations of the Universal Definition of Myocardial Infarction identified patients at high-risk of cardiovascular and noncardiovascular events but was not associated with consistent increases in treatment or improved outcomes. Trials of secondary prevention are urgently required to determine whether this risk is modifiable in patients without type 1 myocardial infarction. Clinical Trial Registration: https://www.clinicaltrials.gov . Unique identifier: NCT01852123.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction
The SCOT-HEART Investigators (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805971 · Cited by 1,390 · cited 2×
“myocardial injury during another illness leads to the identification and treatment of previously unrecognised coronary or structural heart disease, it is plausible that cardiovascular outcomes could improve.(16) Indeed there is increasing evidence that the presence of obstructive coronary disease is the strongest pred…”
BackgroundMethodCompeting risks in epidemiology: possibilities and pitfalls
Andersen, P. K., Geskus, R. B., de Witte, T., & Putter, H. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr213 · Cited by 985 · cited 1×
“excess in non-cardiovascular death in patients with type 2 myocardial infarction and myocardial injury,(11) we applied competing risks methodology in all analyses.(17) The risk of the primary”
MethodAnalytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165795 · Cited by 861
Self-citation
Cited by
Bergmark, B. A., Mathenge, N., Merlini, P. A., Lawrence-Wright, M. B., & Giugliano, R. P. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02391-6 · Cited by 445
DeFilippis, A. P., Chapman, A. R., Mills, N. L., de Lemos, J. A., Arbab-Zadeh, A., Newby, L. K., & Morrow, D. A. (2019) · Circulation · doi:10.1161/circulationaha.119.040631 · Cited by 387
Self-citationKontos, M. C., de Lemos, J. A., Deitelzweig, S. B., Diercks, D. B., Gore, M. O., Hess, E. P., McCarthy, C. P., McCord, J. K., Musey, P. I., Villines, T. C., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.750 · Cited by 260
Sandoval, Y., Apple, F. S., Mahler, S. A., Body, R., Collinson, P. O., Jaffe, A. S., & on behalf of the International Federation of Clinical Chemistry and Laboratory Medicine Committee on the Clinical Application of Cardiac Biomarkers (2022) · Circulation · doi:10.1161/circulationaha.122.059678 · Cited by 202
Self-citationCanty, J. M. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00093.2022 · Cited by 67
Metadata
- Authors
- Chapman, A. R., Adamson, P. D., Shah, A. S. V., Anand, A., Strachan, F. E., Ferry, A. V., Ken Lee, K., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Gray, A., Collinson, P. O., Apple, F., McAllister, D. A., Maguire, D., Fox, K. A. A., Vallejos, C. A., Keerie, C., Weir, C. J., Newby, D. E., Mills, N. L., Tuck, C., Bularga, A., Wereski, R., Sandeman, D., Stables, C. L., Tsanasis, A., Marshall, L., Stewart, S. D., Fujisawa, T., Hautvast, M., McPherson, J., McKinlay, L., Walker, S., Ford, I., Walker, S., Amoils, S., Stevens, J., Norrie, J., Andrews, J., Adamson, P., Moss, A., Anwar, M., Hung, J., Walker, S., Malo, J., Fischbacher, C., Croal, B., Leslie, S. J., Parker, R., Walker, A., Harkess, R., Tuck, C., Wackett, T., Armstrong, R., Flood, M., Stirling, L., MacDonald, C., Sadat, I., Finlay, F., Charles, H., Linksted, P., Young, S., Alexander, B., & Duncan, C.
- Venue
- Circulation
- Published
- 2020-01-21
- Volume
- 141
- Issue
- 3
- Pages
- 161-171
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2980238487
- Cited by
- 211
- References
- 3
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. https://app.cochat.ai/papers/10.1161/circulationaha.119.042960
- The paper
- Chapman, A. R., Adamson, P. D., Shah, A. S. V., Anand, A., Strachan, F. E., Ferry, A. V., Ken Lee, K., Berry, C., Findlay, I., Cruikshank, A., Reid, A., Gray, A., Collinson, P. O., Apple, F., McAllister, D. A., Maguire, D., Fox, K. A. A., Vallejos, C. A., Keerie, C., . . . Duncan, C. (2020). High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. Circulation. https://doi.org/10.1161/circulationaha.119.042960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.